A confirmatory study of Bryostatin-1 in advanced Alzheimer's disease patients not taking memantine as background therapy

Trial Profile

A confirmatory study of Bryostatin-1 in advanced Alzheimer's disease patients not taking memantine as background therapy

Planning
Phase of Trial: Phase II

Latest Information Update: 11 Jan 2018

At a glance

  • Drugs Bryostatin-1 (Primary)
  • Indications Alzheimer's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Jan 2018 New trial record
    • 05 Jan 2018 According to a Neurotrope BioScience media release, the company is in discussions with a leading academic institution to design and conduct the trial and is expected to begin in the first half of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top